TLRY - Tilray CEO Says US Cannabis Consumers Are Confused About Regulation 'Something's Got To Happen' | Benzinga

As Canada's legal marijuana program hits its fifth anniversary showing mixed results, the CEO of one of the largest cannabis companies in the world expresses his opinion on the industry. For Tilray Brands’ (NASDAQ: TLRY) Irwin Simon, it’s been an amazing five years.

"It’s amazing,” Simon said on Tuesday’s Bloomberg Markets. "I sit here today and Canada is the only country in the world where recreational cannabis is legal.”

Tilray does not sell marijuana products in the U.S. because it's illegal on the federal level, which is why the company has expanded its U.S. focus to spirits, beer and food in addition to its medical marijuana operations in Europe, he noted.

Earlier this week, Tilray Medical, a division of Tilray Brands announced its contribution to an independent clinical trial to research the efficacy of medical cannabis as a treatment for glioblastoma, which is a severe form of brain cancer.

See Also: Full story available on Benzinga.com